Keeping Track of the Most Recent Treatment Updates

LAURA S. WOOD, RN, MSN, OCN | September 08, 2019


At the 3rd Annual School of Nursing Oncology, Oncology Nursing News® had the chance to sit down with Laura S. Wood, RN, MSN, OCN, renal cancer research coordinator at the Cleveland Clinic Taussig Cancer Center and one of the co-chairs of the School of Oncology Nursing, and discuss why she believes there are currently so many updates for various malignancies and where these updates are going.
 
 

TRANSCRIPTION

So, we're seeing quite a few updates in the treatment options for a variety of malignancies. That really goes back to better understanding the pathobiology of various cancers and understanding the role of the immune system and being able to target, and or reactivate, the immune system and recognizing that that plays a role in all different malignancies. And so, the clinical trial data has really matured and enrollment in clinical trials has increased our ability to answer those questions and identify those treatment options that are appropriate and those that are not appropriate for FDA approval and treatment. 

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.